GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmaids Pharmaceuticals Ltd (BOM:524572) » Definitions » Cyclically Adjusted Book per Share

Pharmaids Pharmaceuticals (BOM:524572) Cyclically Adjusted Book per Share : ₹9.83 (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Pharmaids Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pharmaids Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2025 was ₹16.820. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹9.83 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Pharmaids Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pharmaids Pharmaceuticals was 6.10% per year. The lowest was 6.10% per year. And the median was 6.10% per year.

As of today (2025-06-01), Pharmaids Pharmaceuticals's current stock price is ₹61.88. Pharmaids Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹9.83. Pharmaids Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 6.30.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharmaids Pharmaceuticals was 7.95. The lowest was 1.01. And the median was 1.98.


Pharmaids Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Pharmaids Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaids Pharmaceuticals Cyclically Adjusted Book per Share Chart

Pharmaids Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.38 7.71 8.06 8.81 9.83

Pharmaids Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.81 - 9.50 - 9.83

Competitive Comparison of Pharmaids Pharmaceuticals's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmaids Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaids Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmaids Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharmaids Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Pharmaids Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharmaids Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=16.82/157.5517*157.5517
=16.820

Current CPI (Mar. 2025) = 157.5517.

Pharmaids Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 99.841 0.000
201509 5.008 101.753 7.754
201512 0.000 102.901 0.000
201603 4.161 102.518 6.395
201606 0.000 105.961 0.000
201609 3.675 105.961 5.464
201612 0.000 105.196 0.000
201703 4.192 105.196 6.278
201706 0.000 107.109 0.000
201709 3.388 109.021 4.896
201712 0.000 109.404 0.000
201803 3.059 109.786 4.390
201806 2.954 111.317 4.181
201809 2.688 115.142 3.678
201812 2.791 115.142 3.819
201903 24.661 118.202 32.871
201906 0.000 120.880 0.000
201909 2.140 123.175 2.737
201912 7.817 126.235 9.756
202003 8.179 124.705 10.333
202006 0.000 127.000 0.000
202009 8.218 130.118 9.951
202012 8.228 130.889 9.904
202103 8.269 131.771 9.887
202106 0.000 134.084 0.000
202109 8.350 135.847 9.684
202112 8.363 138.161 9.537
202203 8.410 138.822 9.545
202206 0.000 142.347 0.000
202209 6.101 144.661 6.645
202212 0.000 145.763 0.000
202303 10.453 146.865 11.214
202306 0.000 150.280 0.000
202309 9.597 151.492 9.981
202312 0.000 152.924 0.000
202403 20.428 153.035 21.031
202406 0.000 155.789 0.000
202409 19.041 157.882 19.001
202412 0.000 158.323 0.000
202503 16.820 157.552 16.820

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Pharmaids Pharmaceuticals  (BOM:524572) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharmaids Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=61.88/9.83
=6.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharmaids Pharmaceuticals was 7.95. The lowest was 1.01. And the median was 1.98.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pharmaids Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Pharmaids Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaids Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
HMT Factory Road, Unit 201, Brigade Rubix, 20/14, Peenya Plantation, Bangalore, KA, IND, 560013
Pharmaids Pharmaceuticals Ltd is an India-based pharmaceutical company. It is mainly engaged in the business contract research and manufacturing services. The products are offered in the areas of hospital care products, skin care products, specialty chemicals, and others. It generates revenue from the sale of its products.

Pharmaids Pharmaceuticals Headlines

No Headlines